USPTO 2015–2025 USPTO PatentsView US Corporation

Halozyme, Inc.

USPTO PatentsView assignee record - 50 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Halozyme ranks #6,659 of 49,997 tracked US assignees by granted-patent volume, with 50 patents across 8 technology areas.

#6,659
of 49,997 US assignees by volume
Top 9%
by Innovation Score (53.6/100)
29.3
avg claims per patent
+0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6659 · US Corporation #6,659 · 50 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-SMALL 50 grants
  • UPPER-Q #6,659/49,997
  • PHOTO-FINISH Gauthier Biomedical
  • CPC-NARROW A61K · 8 areas
  • INNOV-PAR 53.6/100
  • CLAIMS-DENSE 29.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-FLAT +0% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Gauthier Biomedical, Inc (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Halozyme

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Halozyme's Innovation Score is 53.6/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Halozyme's grants concentrate

Halozyme, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 94% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (15 grants) versus a trough of 1 in 2022. By volume, Halozyme sits between Gustav Klauke GMBH and Hyper Ice, Inc..

Halozyme's three-year grant acceleration

Halozyme, Inc. shows 18 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Halozyme's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Halozyme holds 50 patents at rank #6,659, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Halozyme

By rank, the assignees closest to #6,659 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Halozyme's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Halozyme, neither rank-band nor same-CPC leaders (those blocks stay above).

Halozyme's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 9% higher than 91% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20152016201720182019202020212022202320242025 4
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Halozyme, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 6.0%
2016 5 10.0%
2017 6 12.0%
2018 6 12.0%
2019 3 6.0%
2020 2 4.0%
2021 3 6.0%
2022 1 2.0%
2023 2 4.0%
2024 15 30.0%
2025partial year 4 8.0%

Where it ranks

Overall rank by patents

#6,659

of 49,997 tracked assignees

Innovation Score

53.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Halozyme, Inc.'s patent record in context - here's where to go next.

  • Halozyme, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 94% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #6,659 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Halozyme, Inc. against Gustav Klauke GMBH, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 53.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.